For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Phio Pharmaceuticals Corp’s stock clocked out at $2.47, down -11.47% from its previous closing price of $2.79. In other words, the price has decreased by -$11.47 from its previous closing price. On the day, 0.52 million shares were traded.
Ratios:
To gain a deeper understanding of PHIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.58 and its Current Ratio is at 10.58. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 09 ’25 when Bitterman Robert J bought 1,500 shares for $2.75 per share. The transaction valued at 4,125 led to the insider holds 25,149 shares of the business.
Bitterman Robert J bought 3,000 shares of PHIO for $5,310 on May 21 ’25. The Chairman, Pres & CEO now owns 22,449 shares after completing the transaction at $1.77 per share. On May 22 ’25, another insider, Bitterman Robert J, who serves as the Chairman, Pres & CEO of the company, bought 1,200 shares for $1.78 each. As a result, the insider paid 2,136 and bolstered with 23,649 shares of the company.
Stock Price History:
Over the past 52 weeks, PHIO has reached a high of $9.79, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is 27.78%, while the 200-Day Moving Average is calculated to be 6.34%.
Shares Statistics:
A total of 4.78M shares are outstanding, with a floating share count of 4.74M. Insiders hold about 1.26% of the company’s shares, while institutions hold 3.99% stake in the company.
